• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Viemed Healthcare Inc.

    4/29/25 3:48:44 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care
    Get the next $VMD alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 5)


    VIEMED HEALTHCARE, INC.

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)


    92663R105

    (CUSIP Number)


    03/31/2025

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)






    SCHEDULE 13G

    CUSIP No.
    92663R105


    1Names of Reporting Persons

    THRIVENT FINANCIAL FOR LUTHERANS
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    WISCONSIN
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    14,328.00
    6Shared Voting Power

    2,690,672.00
    7Sole Dispositive Power

    14,328.00
    8Shared Dispositive Power

    2,690,672.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    2,705,000.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    6.8 %
    12Type of Reporting Person (See Instructions)

    IA, IC

    Comment for Type of Reporting Person:  Item 5, Item 7 and Item 9 - Thrivent Financial for Lutherans disclaims beneficial ownership of the 14,328 shares held in the Thrivent Financial Defined Benefit Plan Trust. Item 6, Item 8 and Item 9 - Represents 707,051 shares held by registered investment companies for which Thrivent Financial for Lutherans serves as investment adviser, and 1,983,621 shares held by registered investment companies for which Thrivent Asset Management, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Thrivent Financial for Lutherans, serves as investment adviser. Item 11 - The percentage calculations used herein are based on the statement in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission on March 10, 2025, that there were 39,21,618 shares of Viemed Healthcare, Inc. Common Stock outstanding as of February 18, 2025.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    VIEMED HEALTHCARE, INC.
    (b)Address of issuer's principal executive offices:

    625 E. KALISTE SALOOM RD., 625 E. KALISTE SALOOM RD., LAFAYETTE, LOUISIANA, 70508.
    Item 2. 
    (a)Name of person filing:

    Thrivent Financial for Lutherans
    (b)Address or principal business office or, if none, residence:

    901 Marquette Avenue, Suite 2500 Minneapolis, MN 55402
    (c)Citizenship:

    Thrivent Financial for Lutherans is a Wisconsin fraternal benefit society.
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    92663R105
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    2,705,000 Thrivent Financial for Lutherans disclaims beneficial ownership of the 14,328 shares held in the Thrivent Financial Defined Benefit Plan Trust. Represents 707,051 shares held by registered investment companies for which Thrivent Financial for Lutherans serves as investment adviser, and 1,983,621 shares held by registered investment companies for which Thrivent Asset Management, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Thrivent Financial for Lutherans, serves as investment adviser.
    (b)Percent of class:

    6.8 The percentage calculations used herein are based on the statement in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the Securities and Exchange Commission on March 10, 2025, that there were 39,521,618 shares of Viemed Healthcare, Inc. Common Stock outstanding as of February 18, 2025.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    14,328 Thrivent Financial for Lutherans disclaims beneficial ownership of these shares held in the Thrivent Financial Defined Benefit Plan Trust.

     (ii) Shared power to vote or to direct the vote:

    2,690,672 Represents 707,051 shares held by registered investment companies for which Thrivent Financial for Lutherans serves as investment adviser, and 1,983,621 shares held by registered investment companies for which Thrivent Asset Management, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Thrivent Financial for Lutherans, serves as investment adviser.

     (iii) Sole power to dispose or to direct the disposition of:

    14,328 Thrivent Financial for Lutherans disclaims beneficial ownership of these shares held in the Thrivent Financial Defined Benefit Plan Trust.

     (iv) Shared power to dispose or to direct the disposition of:

    2,690,672 Represents 707,051 shares held by registered investment companies for which Thrivent Financial for Lutherans serves as investment adviser, and 1,983,621 shares held by registered investment companies for which Thrivent Asset Management, LLC, a Delaware limited liability company and a wholly-owned subsidiary of Thrivent Financial for Lutherans, serves as investment adviser.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    THRIVENT FINANCIAL FOR LUTHERANS
     
    Signature:/s/ David S. Royal
    Name/Title:Chief Financial Officer
    Date:04/29/2025
    Get the next $VMD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VMD

    DatePrice TargetRatingAnalyst
    11/3/2021$13.00 → $9.00Outperform
    RBC Capital
    More analyst ratings

    $VMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital reiterated coverage on Viemed Healthcare with a new price target

    RBC Capital reiterated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $9.00 from $13.00 previously

    11/3/21 9:01:34 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Royal Bank of Canada initiated coverage on Viemed Healthcare with a new price target

    Royal Bank of Canada initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

    3/11/21 8:08:09 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    RBC Capital initiated coverage on Viemed Healthcare with a new price target

    RBC Capital initiated coverage of Viemed Healthcare with a rating of Outperform and set a new price target of $13.00

    3/5/21 8:11:16 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kaushal Nitin converted options into 15,732 shares, increasing direct ownership by 12% to 142,575 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    8/20/25 6:22:41 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Director Smokoff Timothy converted options into 15,732 shares, increasing direct ownership by 20% to 95,518 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    8/20/25 6:22:15 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Director Dobbs Randy E. converted options into 17,784 shares, increasing direct ownership by 17% to 125,490 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    8/20/25 6:20:37 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Financials

    Live finance-specific insights

    View All

    Viemed Healthcare Announces First Quarter 2025 Financial Results

    LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2025 were $59.1 million, representing an increase of $8.5 million, or 17%, over net revenues reported for the comparable quarter ended March 31, 2024. Net income attributable to Viemed for t

    5/7/25 4:45:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces First Quarter 2025 Earnings Conference Call Details

    LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: (866) 682-6100 (US Toll-Free) +1 (862) 298-0702 (International) Live Audio Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=0dOJVhdb Following the live call, a replay will be available in the Investor Relations section of the Company's website at www.viemed.com. ABOUT VIE

    4/22/25 4:30:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces Record 2024 Financial Results

    LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025. Fourth Quarter and Full Year Operational Highlights (all dollar amounts are USD): Net revenues for the quarter ended December 31, 2024 reached a new Company record of $60.7 million representing an increase of $10.0 million, or 20%, over net revenues reported for the comparable quarter ended Decembe

    3/10/25 5:00:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Leadership Updates

    Live Leadership Updates

    View All

    Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois

    LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has entered into a definitive agreement to acquire Illinois-based Lehan's Medical Equipment ("Lehan"), a healthcare company offering home medical equipment with specialties in respiratory care and women's health. "Operating for nearly 80 years, Lehan has established a well-deserved reputation for its expertise in home medical equipment with a particular emphasis on women's health and a deep commitment to community engagement," said Viemed Chief

    5/6/25 8:30:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health

    LAFAYETTE, La., April 02, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced the finalization of its strategic partnership with East Alabama Health ("EAH"), providing Viemed with the controlling interest of East Alabama HomeMed, LLC ("HomeMed"). HomeMed provides home medical equipment services to patients within the EAH network as well as those in the surrounding areas of Eastern Alabama. "We are thrilled to join forces with the exceptional team at East Alabama Health to deliver best-in-class home medical services to their patients and expand Home

    4/2/24 9:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces Voting Results From Its Annual General Meeting of Shareholders

    LAFAYETTE, La., June 13, 2023 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD, TSX:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced the voting results from its annual general meeting of shareholders held on June 13, 2023 (the "Meeting") in Lafayette, Louisiana. The total number of shares represented in person or by proxy at the Meeting was 27,309,147, representing 71.33% of the total issued and outstanding shares in the capital of the Company. Election of Directors The eight candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's m

    6/13/23 5:00:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Viemed Healthcare Inc. (Amendment)

    SC 13D/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

    2/15/24 9:27:58 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G/A filed by Viemed Healthcare Inc. (Amendment)

    SC 13G/A - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

    2/15/24 9:27:32 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Viemed Healthcare Inc.

    SC 13G - VIEMED HEALTHCARE, INC. (0001729149) (Subject)

    2/14/24 4:51:42 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Viemed Healthcare Announces Share Repurchase Program

    LAFAYETTE, La., June 09, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that its Board of Directors has authorized a share repurchase program, effective through June 2026. Under the share repurchase program, Viemed may purchase up to 1,976,441 common shares of the Company ("the Common Shares") from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 31, 2025. The Company intends to repurchase Common Shares through open market purchases, block purchases o

    6/9/25 8:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare to Present and Host 1x1 Investor Meetings at the 15th Annual East Coast Ideas Investor Conference on June 11th in New York

    LAFAYETTE, La., June 03, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced it will present at the East Coast IDEAS Investor Conference on Wednesday June 11, 2025 at The Westin Times Square in New York, NY. Viemed's presentation is scheduled to begin at 11:30am ET. The presentation is webcast and can be accessed through the conference host's main website: https://www.threepartadvisors.com/east-coast and in the investor relations section of the Company's website: http://viemed.com/investors. ABOUT VIEMED HEALTHCARE, INC. Viemed is an

    6/3/25 8:00:00 AM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Announces First Quarter 2025 Financial Results

    LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2025 were $59.1 million, representing an increase of $8.5 million, or 17%, over net revenues reported for the comparable quarter ended March 31, 2024. Net income attributable to Viemed for t

    5/7/25 4:45:00 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    SEC Filings

    View All

    SEC Form S-8 filed by Viemed Healthcare Inc.

    S-8 - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

    8/12/25 4:39:52 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 10-Q filed by Viemed Healthcare Inc.

    10-Q - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

    8/6/25 5:06:51 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    Viemed Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - VIEMED HEALTHCARE, INC. (0001729149) (Filer)

    8/6/25 5:04:31 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care

    $VMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Heltz Sabrina bought $19,977 worth of shares (2,820 units at $7.08), increasing direct ownership by 7% to 41,040 units (SEC Form 4)

    4 - VIEMED HEALTHCARE, INC. (0001729149) (Issuer)

    5/14/24 5:25:11 PM ET
    $VMD
    Misc Health and Biotechnology Services
    Health Care